Oaktree Acquisition Corp. III Life Sciences
OACC- Exchange
- Nasdaq
- Industry
- Blank Checks
- SEC CIK
- 0002029769
No open-market purchases or sales by Oaktree Acquisition Corp. III Life Sciences insiders were filed in the last 90 days; 51 institutions reported holding it in 13F filings for Q2 2026, worth $181.5M in total; no superinvestor holds it.
Q2 2026 vs. Q1 2026
How the institutions holding Oaktree Acquisition Corp. III Life Sciences changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Of which not filed for Q2 2026 | Q2 2026 | Change |
|---|---|---|---|---|
| Holders | 51 | 1 | 51 | +1 |
| Shares | 16.9M | 720.0K | 17.0M | +774.2K (+4.8%) |
| Value | $178.9M | $7.62M | $181.5M | +$10.2M (+6.0%) |
1 institution that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so the changes leave them out.
New holders (3)
Institutions that held Oaktree Acquisition Corp. III Life Sciences at the end of Q2 2026 but not at the end of Q1 2026.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Boussard & Gavaudan Gestion SAS | 720,000 | $7.70M | 0.39% |
| SkyView Investment Advisors, LLC | 115,002 | $1.23M | 0.97% |
| HRT Financial LP | 14,920 | $159.0K | 0.00% |
Sold out (2)
Institutions that held Oaktree Acquisition Corp. III Life Sciences at the end of Q1 2026 and filed for Q2 2026 without it.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| HighTower Advisors, LLC | 510,836 | $5.40M |
| Citadel Advisors LLC | 10,253 | $108.9K |
Not filed for Q2 2026 yet (1)
Institutions that held Oaktree Acquisition Corp. III Life Sciences at the end of Q1 2026 and haven't filed a 13F for Q2 2026. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| Boussard & Gavaudan Investment Management LLP | 720,000 | $7.62M |